Looking for a partner for your health monitoring project?
Contact us today if you would like to learn more. Or refer to our expertise in Digital Health for more information on how we could help you.
Modernizing healthcare with advanced 24/7 optical monitoring technology
© CSEM
Revolutionizing patient health management
In today’s rapidly evolving healthcare landscape, continuous monitoring of vital signs represents a transformative leap forward, offering improved patient outcomes and reducing the burden on healthcare systems. In collaboration with CSEM, rheo is introducing an advanced all-in-one sensor powered by cutting-edge optical technology. This breakthrough promises to enhance inpatient care and provide real-time health data, particularly in hospital ward settings.
A comprehensive approach to vital sign monitoring
Rheo’s device redefines patient monitoring by offering a seamless and non-invasive solution to track vital signs, including blood pressure, pulse rate, respiration rate, SpO2 (blood oxygen levels), and core body temperature. The sensor, worn comfortably on the upper arm, ensures continuous data collection, eliminating the gaps left by traditional intermittent measurements. In most hospital wards, vital signs are typically checked every 4–8 hours, leaving patients unmonitored for extended periods. Rheo’s innovation transforms this practice by providing real-time data that enable timely interventions, enhancing patient safety and promoting faster recovery.
CSEM’s optical technology: The core of innovation
At the core of this innovation lies CSEM’s Optical Cardiovascular Monitoring Technology (oCMT), a pioneering solution in non-invasive health tracking. This technology employs photoplethysmography (PPG), which uses light to measure blood volume changes beneath the skin. “By integrating advanced sensors with proprietary algorithms, oCMT delivers precise measurements of heart rate, blood pressure, respiratory patterns, pulse oximetry, and pulse rate with patented medical-grade accuracy,” says Damien Ferrario, Group Leader, MedTech, CSEM.
CSEM’s open foundry service for TFLN PICs
Rheo’s sensor addresses a critical challenge in hospital settings: reliance on manual and infrequent vital sign measurements. “By automating this process, our device ensures that even subtle changes in a patient’s condition are detected early, reducing medical emergencies and enabling personalized treatment plans tailored to each patient’s unique needs,” explains Philipp Vetter, CEO & Founder of rheo. “The automation also alleviates the workload on nurses and healthcare professionals, allowing them to focus more on direct patient care. Additionally, the sensor integrates seamlessly with existing hospital systems, enhancing communication and facilitating data-driven decision-making.”
Studies show that automated ward monitoring can reduce rescue events and improve key patient-centered clinical outcomes. For example, in an orthopedic ward, the implementation of a continuous pulse oximetry surveillance system has reduced the number of rescue events from 3.4 to 1.2 per 1000 patient discharges 1.
Prospects and advancements
A clinical evaluation has already demonstrated the reliability and accuracy of rheo’s device in measuring vital signs. Looking ahead, rheo and CSEM are exploring ways to enhance the device further. These advancements will bolster the device’s role as a cornerstone in healthcare innovation.
The collaboration between rheo and CSEM represents a bold step toward smarter, more efficient healthcare systems. By combining advanced technology with a commitment to accessibility, this all-in-one sensor sets new standards for patient monitoring. It not only improves outcomes in hospital settings but also holds the potential to transform home healthcare and proactive health management.